102 related articles for article (PubMed ID: 535391)
1. Host responses to infection with Yersinia enterocolitica.
Carter PB; MacDonald TT; Collins FM
Contrib Microbiol Immunol; 1979; 5():346-50. PubMed ID: 535391
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the protective and cross-reacting antigens of Brucella spp., Yersinia enterocolitica 0:9 and Salmonella serotypes of Kauffmann-White group N.
Corbel MJ
Contrib Microbiol Immunol; 1979; 5():50-63. PubMed ID: 119612
[TBL] [Abstract][Full Text] [Related]
3. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune reaction in Balb/c mice infected with Yersinia enterocolitica.
Zaremba M; Kacprzak-Wiatr A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):619-23. PubMed ID: 749815
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the virulence gene products of Yersinia enterocolitica in the immune response of infected mice.
Takeuchi O; Suzuki T; Kawamura I; Kobayashi N; Takizawa-Hashimoto A; Mitsuyama M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):321-9. PubMed ID: 16019194
[TBL] [Abstract][Full Text] [Related]
6. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
7. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
Heesemann J; Gaede K; Autenrieth IB
APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
[TBL] [Abstract][Full Text] [Related]
8. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract.
Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM
Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590
[TBL] [Abstract][Full Text] [Related]
10. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
11. Roles of V antigen in promoting virulence and immunity in yersiniae.
Une T; Brubaker RR
J Immunol; 1984 Oct; 133(4):2226-30. PubMed ID: 6381597
[TBL] [Abstract][Full Text] [Related]
12. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
Singh AK; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
[TBL] [Abstract][Full Text] [Related]
13. Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.
Matteoli G; Fahl E; Warnke P; Müller S; Bonin M; Autenrieth IB; Bohn E
BMC Microbiol; 2008 Sep; 8():153. PubMed ID: 18803824
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
[TBL] [Abstract][Full Text] [Related]
16. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
[TBL] [Abstract][Full Text] [Related]
17. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
[TBL] [Abstract][Full Text] [Related]
18. [Experimental infection in mice with Yersinia enterocolitica (strain biotype 4, serogroup O:3, phage type VIII): growth of the inoculum in athymic or cyclophosphamide treated mice (author's transl)].
Alonso JM; Mazigh D; Bercovier H; Mollaret HH
Ann Microbiol (Paris); 1978 Jul; 129B(1):27-36. PubMed ID: 718016
[TBL] [Abstract][Full Text] [Related]
19. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.
Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM
Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042
[TBL] [Abstract][Full Text] [Related]
20. Experimental intramammary infection of cows with Yersinia enterocolitica O9: cellular and immunologic responses.
Mittal KR; Barnum DA; Tizard IR
Am J Vet Res; 1981 Feb; 42(2):311-3. PubMed ID: 6789723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
